CVS will sell a generic version of Impax Laboratories’ Adrenaclick treatment for $109.99 per two-pack, down from $200. In comparison, Mylan’s generic epinephrine auto-injector cost $300 for a two-pack, about 50 percent less than EpiPen’s $608 list price. Mylan announced it would be releasing the generic device in December after taking widespread criticism for raising its price for EpiPen by more than 400 percent since 2009.
In other Mylan news, Bloomfield, Conn.-based health insurer Cigna announced it is dropping coverage for Mylan’s EpiPen and EpiPen Jr. auto-injectors in favor of its generic alternative, according to the payer’s prescription drug list changes.
More articles on supply chain:
7 must-reads for supply chain leaders this week
Op-ed: The 1 way pharma can get on Trump’s good side
Implanted abdominal pumps may malfunction in MRIs, FDA warns
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
